Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06319300
NA

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

Sponsor: Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

Our study was a single-blind, randomised, controlled, multicentre study. The study was planned to enrol 142 patients with T2DM admitted to general wards who required subcutaneous insulin therapy. Participants were randomly divided into two groups in the ratio of 1:1, one group with an artificial intelligence-assisted insulin decision system to adjust insulin doses for blood glucose control, and the other group received clinician-instituted insulin dose adjustments for blood glucose control. The effectiveness and safety of the system was confirmed by comparing the glycaemic control and risk of adverse events between the two groups.

Official title: Efficacy and Safety of the Artificial Intelligence-assisted Insulin Dose Adjustment System for Glycaemic Control in Patients With Type 2 Diabetes Mellitus in General Wards: a Multicentre, Single-blind, Randomised Controlled Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

144

Start Date

2024-04-19

Completion Date

2025-09-20

Last Updated

2026-06-23

Healthy Volunteers

No

Conditions

Interventions

DEVICE

AI-assisted insulin dose adjustment model

We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients

OTHER

doctor's insulin dose adjustment

participants' insulin doses are adjusted by doctors

Locations (1)

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China